MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Tarsus Pharmaceuticals, Inc. (TARS)
Tarsus Pharmaceuticals, Inc. (TARS)
source: myfinsight.com
Download
Download image
Comprehensive loss
-$7,646K
(69.68%↑ Y/Y)
Interest income
$3,722K
(7.76%↑ Y/Y)
Net loss
-$6,967K
(72.27%↑ Y/Y)
Unrealized gain (loss) on
marketable securities and...
-$679K
(-622.34%↓ Y/Y)
Total other income
(expense), net
$1,507K
(29.91%↑ Y/Y)
Product
$145,387K
License And
Collaboration
$16,667K
Interest expense
$2,128K
(-3.84%↓ Y/Y)
Other income
(expense), net
-$87K
(-7.41%↓ Y/Y)
Loss from operations
before other income...
-$6,122K
(76.70%↑ Y/Y)
Provision for income taxes
$2,352K
Total revenues
$162,054K
(106.87%↑ Y/Y)
Total operating
expenses
$168,176K
(60.76%↑ Y/Y)
Back